All cases of AIHA displayed severe hemolysis, with transfusion requirement (80%), high prevalence of DAT negativity (38%), relapse in about 50% of patients, and mortality as high as 17% [8, 23, 24]. Here, SLC6A3 is linked to autoimmune hemolytic anemia.